Denosumab

Denosumab is a medication used to strengthen bones and prevent fractures, especially in conditions like osteoporosis. It works by targeting a protein called RANKL, which promotes the activity of cells that break down bone. By inhibiting RANKL, denosumab reduces bone loss, helping to maintain or increase bone density. It is administered as a shot usually every six months and is prescribed for individuals at higher risk of fractures due to weak or fragile bones. Overall, denosumab helps improve bone strength and reduce the likelihood of breaks caused by fragile bones.